SCHEDULE 13G/A: Armistice Capital and Steven Boyd Maintain 9.99% Stake in NanoVibronix, Inc.

Armistice Capital, LLC and Steven Boyd have filed an amended Schedule 13G, reporting a shared beneficial ownership of 349,284 common shares, representing 9.99% of NanoVibronix, Inc.

Summary

• Armistice Capital, LLC and Steven Boyd are the Reporting Persons in this Schedule 13G Amendment No. 2 filing.
• The filing pertains to common stock, par value $0.001 per share, of NanoVibronix, Inc. (Issuer).
• The Reporting Persons collectively beneficially own 349,284 shares of NanoVibronix, Inc.'s common stock.
• This ownership represents 9.99% of the class of securities.
• Armistice Capital, LLC and Steven Boyd share both voting power and dispositive power over all 349,284 shares.
• Armistice Capital, LLC, a Delaware entity, acts as the investment manager for Armistice Capital Master Fund Ltd., which is the direct holder of the shares.
• Steven Boyd, a U.S. citizen, is the managing member of Armistice Capital, LLC.
• The filing certifies that the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing the control of the issuer.

Sentiment

Score: 5

Explanation: The document is a routine regulatory filing (Schedule 13G/A) disclosing beneficial ownership, and as such, it does not inherently convey positive or negative sentiment regarding the issuer's performance or prospects. It is a factual update on a significant shareholder's stake.

Positives

• A significant institutional investor, Armistice Capital, LLC, along with Steven Boyd, maintains a substantial 9.99% stake in NanoVibronix, Inc., indicating continued interest in the company.

Negatives

• No negative information regarding NanoVibronix, Inc.'s performance or operations is presented in this beneficial ownership filing.

Risks

• None mentioned in this filing, as it is a routine beneficial ownership disclosure.

Future Outlook

None provided in this filing, as it is a routine beneficial ownership disclosure.

Management Comments

• The Reporting Persons certify that the securities were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities.

Industry Context

This filing is a routine disclosure of beneficial ownership and does not provide industry-specific context or trends for NanoVibronix, Inc.

Comparison to Industry Standards

• Not applicable; this filing is a disclosure of beneficial ownership and does not contain performance metrics for comparison against industry standards or specific comparable companies/projects.

Management Changes

Corporate Governance

Legal Proceedings

• None mentioned in this filing.

Related Party Transactions

• None mentioned in this filing.

Stakeholder Impact

• This filing primarily impacts shareholders by providing transparency on significant ownership stakes. It does not directly detail impacts on employees, customers, suppliers, or creditors.

Next Steps

• No specific future actions, events, or milestones for the issuer are mentioned in this beneficial ownership filing.

Key Dates

Keywords

NanoVibronix, Armistice Capital, Steven Boyd, Schedule 13G, beneficial ownership, common stock, SEC filing, investment